Personal information

Schizophrenia, Animal Models, CB2 receptor, Cognitive Neuroscience, Neuropharmacology
Brazil

Biography

Brenda has a degree in Biomedical Sciences at Grande Rio University (2019) and Masters in Pharmacology and Medicinal Chemistry (2022) at the Federal University of Rio de Janeiro (UFRJ) . Currently is a PhD student at the Pharmacology and Medicinal Chemistry program of UFRJ woking with new α7 nicotinic receptor drug candidates for the treatment of schizophrenia. Brenda has experience in neuropharmacology, cognitive neuroscience, animal models of schizophrenia and behavioral tasks.

Activities

Employment (1)

Laboratory of Molecular Pharmacology: Rio de Janeiro, Rio de Janeiro, BR

Research Trainee (Federal University of Rio de Janeiro)
Employment
Source: Self-asserted source
Brenda S. Andrade

Education and qualifications (3)

Universidade Federal do Rio de Janeiro Instituto de Ciências Biomédicas: Rio de Janeiro, RJ, BR

2022-08 to present | PhD (Institute of Biomedical Sciences)
Education
Source: Self-asserted source
Brenda S. Andrade

Universidade Federal do Rio de Janeiro Instituto de Ciências Biomédicas: Rio de Janeiro, RJ, BR

2020-03 to 2022-08 | Masters Student (Institute of Biomedical Sciences)
Education
Source: Self-asserted source
Brenda S. Andrade

Grande Rio University: Duque de Caxias, RJ, BR

2016 to 2019 | Bachelor of Biomedical Sciences
Education
Source: Self-asserted source
Brenda S. Andrade

Professional activities (1)

Brazilian Society of Neurosciences and Behavior - SBNeC: São Paulo, São Paulo, BR

Membership
Source: Self-asserted source
Brenda S. Andrade

Works (5)

Age-dependent memory impairment induced by co-exposure to nicotine and a synthetic cannabinoid in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry
2023-12 | Journal article
Part of ISSN: 0278-5846
Contributors: Patricia Felix Rolo Gonçalves; Luis Eduardo Duarte Nunes; Brenda da Silva Andrade; Mariana Oliveira Lopes da Silva; Isis Nem de Oliveira Souza; Iranaia Assunção-Miranda; Newton Gonçalves Castro; Gilda Angela Neves
Source: Self-asserted source
Brenda S. Andrade

Alkylamides from Acmella oleracea: antinociceptive effect and molecular docking with cannabinoid and TRPV1 receptors

Natural Product Research
2023-09-17 | Journal article
Contributors: Raíssa M. Kao Yien; Anne Caroline C. Gomes; Rodolfo Goetze Fiorot; Ana Luísa Palhares Miranda; Gilda A. Neves; Brenda da Silva Andrade; Fernanda N. Costa; Jorge Luiz Mendonça Tributino; Naomi Kato Simas
Source: check_circle
Crossref

Could the Urease of the Gut Bacterium Proteus mirabilis Play a Role in the Altered Gut–Brain Talk Associated with Parkinson’s Disease?

Microorganisms
2023-08-09 | Journal article
Part of ISSN: 2076-2607
Contributors: Grahl, M. V. C.; Brenda da Silva Andrade; Ana Paula A. Perin; Gilda A. Neves; Laura de Souza Duarte; Augusto Frantz Uberti; Kelvin Siqueira Hohl; Cristian Follmer; Celia R Carlini; Brenda S. Andrade
Source: Self-asserted source
Brenda S. Andrade

Different outcomes of neonatal and adult Zika virus infection on startle reflex and prepulse inhibition in mice

2022-11-09 | Preprint
Contributors: Isis N. O. Souza; Brenda S. Andrade; Paula S. Frost; Romulo L. S. Neris; Daniel Gavino-Leopoldino; Andrea T. Da Poian; Iranaia Assunção-Miranda; Claudia P. Figueiredo; Julia R. Clarke; Gilda A. Neves
Source: check_circle
Crossref

Blockade of cannabinoid type 2 receptor inhibits a working memory impairment relevant for schizophrenia

IBRO Reports
2019-09 | Journal article
Part of ISSN: 2451-8301
Source: Self-asserted source
Brenda S. Andrade